For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Carboplatin + Avastin | Carboplatin in 250mL saline IV over 30 minutes and Avastin (Bevacizumab) 15mg/kg in 100mL saline IV over 60 - 90 minutes | None | None | 1 | 11 | 9 | 11 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Leukopenia | None | Blood and lymphatic system disorders | MedDRA (Unspecified) | View |
| Constipation | None | Gastrointestinal disorders | MedDRA (Unspecified) | View |
| nausea | None | Gastrointestinal disorders | MedDRA (Unspecified) | View |
| Vomiting | None | Gastrointestinal disorders | MedDRA (Unspecified) | View |
| Chest pain | None | General disorders | MedDRA (Unspecified) | View |
| Fatigue | None | General disorders | MedDRA (Unspecified) | View |
| pain | None | General disorders | MedDRA (Unspecified) | View |
| Alanine aminotransferase increased | None | Investigations | MedDRA (Unspecified) | View |
| Alkaline phosphatase increased | None | Investigations | MedDRA (Unspecified) | View |
| Aspartate aminotransferase increased | None | Investigations | MedDRA (Unspecified) | View |
| Creatinine increased | None | Investigations | MedDRA (Unspecified) | View |
| Ear, nose and throat examination abnormal | None | Investigations | MedDRA (Unspecified) | View |
| Hemoglobin | None | Investigations | MedDRA (Unspecified) | View |
| Hemoglobin decreased | None | Investigations | MedDRA (Unspecified) | View |
| Hyperglycemia | None | Investigations | MedDRA (Unspecified) | View |
| Laboratory test abnormal | None | Investigations | MedDRA (Unspecified) | View |
| Leukocytes | None | Investigations | MedDRA (Unspecified) | View |
| Neutrophil count decreased | None | Investigations | MedDRA (Unspecified) | View |
| Neutrophils | None | Investigations | MedDRA (Unspecified) | View |
| Platelet count decreased | None | Investigations | MedDRA (Unspecified) | View |
| Platelets | None | Investigations | MedDRA (Unspecified) | View |
| Weight loss | None | Investigations | MedDRA (Unspecified) | View |
| Anorexia | None | Metabolism and nutrition disorders | MedDRA (Unspecified) | View |
| Dehydration | None | Metabolism and nutrition disorders | MedDRA (Unspecified) | View |
| Headache | None | Nervous system disorders | MedDRA (Unspecified) | View |
| Peripheral sensory neuropathy | None | Nervous system disorders | MedDRA (Unspecified) | View |
| Depression | None | Psychiatric disorders | MedDRA (Unspecified) | View |
| Insomnia | None | Psychiatric disorders | MedDRA (Unspecified) | View |
| Proteinuria | None | Renal and urinary disorders | MedDRA (Unspecified) | View |
| Breast pain | None | Reproductive system and breast disorders | MedDRA (Unspecified) | View |
| Bronchopulmonary hemorrhage | None | Respiratory, thoracic and mediastinal disorders | MedDRA (Unspecified) | View |
| Hemorrhage nasal | None | Respiratory, thoracic and mediastinal disorders | MedDRA (Unspecified) | View |
| Pruritus | None | Skin and subcutaneous tissue disorders | MedDRA (Unspecified) | View |
| Hemorrhage - Other (Specify) | None | Vascular disorders | MedDRA (Unspecified) | View |
| Hypertension | None | Vascular disorders | MedDRA (Unspecified) | View |
| Vascular - Other (Specify) | None | Vascular disorders | MedDRA (Unspecified) | View |